about
Optimal Follow-up of Patients with Viral Hepatitis Improves the Detection of Early-stage Hepatocellular Carcinoma and the Prognosis of Survival.Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial.Clinical course of hepatitis B surface antigen positive subjects following screening: A retrospective observational study from April 2008 to January 2013.Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients.Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C.Whole-body insulin resistance is associated with elevated serum α-fetoprotein levels in patients with chronic hepatitis C.Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis CLow-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trialRecurrent acute pancreatitis caused by a gastric duplication cyst communicating with an aberrant pancreatic ductAn automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C"Weariness" and "unpleasantness" reduce adherence to branched-chain amino acid granules among Japanese patients with liver cirrhosis: results of a single-center cross-sectional surveyDiagnostic accuracy of FibroScan-AST score to identify nonalcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with nonalcoholic fatty liver disease: comparison between M and XL probesMetabolomic-/Lipidomic-based Analysis of Plasma to Diagnose Hepatocellular Ballooning in Patients with Nonalcoholic Fatty Liver Disease: A Multicenter Study
P50
Q37383131-95A880A1-1F31-48C0-AD3C-99045C470A7DQ40871879-86414E06-E758-4DB3-A7C2-26BECC555C70Q41193967-C0D3EF11-9D8B-4329-806A-5BED7AC03899Q41235262-1A28BA19-3078-404D-A65D-7DDA4856639CQ42871777-E64D27C1-1F77-4BAD-B6BE-454622BC57E3Q44575341-555B9031-5FBB-4398-B2CE-61370941A49AQ51144955-9E9DF82D-6A60-4F9E-A4D7-D476EEEF5FDCQ83436407-69AEAE9F-2A27-4CC2-BE8D-E2D6A247B811Q83477164-09C3BCB2-23BE-40A6-A25A-53191BFE728EQ84582971-1C661C07-0AAF-4FD0-9630-C135F4A12FC8Q86381990-B216C1C2-E97A-41BC-BB05-D084ECB9ED8FQ89219090-61B2DDF8-FF5A-4E92-ABE6-B245DBCD9E54Q93245241-7DB1BB86-DB78-4F30-B3D3-419EA6E76886Q95824243-74E0D367-1DAC-428E-97CA-B52257319DA7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Satoshi Oeda
@ast
Satoshi Oeda
@en
Satoshi Oeda
@es
Satoshi Oeda
@nl
type
label
Satoshi Oeda
@ast
Satoshi Oeda
@en
Satoshi Oeda
@es
Satoshi Oeda
@nl
prefLabel
Satoshi Oeda
@ast
Satoshi Oeda
@en
Satoshi Oeda
@es
Satoshi Oeda
@nl
P106
P31
P496
0000-0002-0014-6275